Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan-Reference-Cited by-同舟云学术

Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan

Published:2010-03-03 Issue:3 Volume:91 Page:446-455
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Itoh Kuniaki,Kinoshita Tomohiro,Watanabe Takashi,Yoshimura Kenichi,Okamoto Rumiko,Chou Takaaki,Ogura Michinori,Hirano Masami,Asaoku Hideki,Kurosawa Mitsutoshi,Maeda Yoshiharu,Omachi Ken,Moriuchi Yukiyoshi,Kasai Masaharu,Ohnishi Kazunori,Takayama Nobuyuki,Morishima Yasuo,Tobinai Kensei,Kaba Harumi,Yamamoto Seiichiro,Fukuda Haruhiko,Kikuchi Masahiro,Yoshino Tadashi,Matsuno Yoshihiro,Hotta Tomomitsu,Shimoyama Masanori

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-010-0533-9.pdf

Reference33 articles.

1. Evens AM, Hutchings M, Diehl V. Treatment of Hodgkin lymphoma: the past, present, and future. Nat Clin Pract Oncol. 2008;5:543–56.

2. Franklin J, Pluetschow A, Paus M, Specht L, Anselmo AP, Aviles A, et al. Second malignancy risk associated with treatment of Hodgkin’s lymphoma: meta-analysis of the randomised trials. Ann Oncol. 2006;17:1749–60.

3. Schonfeld SJ, Gilbert ES, Dores GM, Lynch CF, Hodgson DC, Hall P, et al. Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35 511 patients. J Natl Cancer Inst. 2006;98:215–8.

4. Hodgson DC. Hodgkin lymphoma: the follow-up of long-term survivors. Hematol Oncol Clin N Am. 2008;22:233–44.

5. De Bruin ML, Dorresteijn LDA, van’t Veer MB, Krol ADG, van der Pal HJ, Kappelle AC, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101:928–37.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression Patterns of GATA3 in Classical Hodgkin Lymphoma: A Clinico-Pathological Study;Diseases;2024-02-29

2. The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients;Annals of Hematology;2024-01-25

3. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients;Cancers;2024-01-05

4. Increased Turnover of Beta 2 Microglobulin in Circulation serves as Diagnostic and Prognostic Marker for Malignant Lymphoma; A Case Control Predictive Model for Lymphoma Diagnosis;Pakistan Journal of Health Sciences;2023-05-31

5. Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A;Journal of Clinical and Experimental Hematopathology;2021